CNBC's Jim Cramer tempered enthusiasm for Novo Nordisk stock, suggesting investors hold rather than buy after its massive gains driven by blockbuster weight-loss drugs.
Business Facilities magazine has named North Carolina its 'State of the Year' for business climate and economic development, the state's third such win in six years, following a surge of multi-billion dollar investments from tech and manufacturing giants.
Despite modest nominal gains, real wages for U.S. workers are failing to keep pace with the cost of living, with a majority reporting financial strain as structural economic shifts and technological efficiencies redirect gains away from paychecks.
AbbVie's stock presents a complex picture for investors, with recent mixed performance contrasting sharply with its robust multi-year returns. As shares trade below consensus targets, the market weighs near-term headwinds against the pharmaceutical giant's proven track record and pipeline potential.
Amazon is reportedly negotiating a landmark investment of up to $50 billion in OpenAI, a move that would cement its position as a dominant AI investor. The talks coincide with a wave of layoffs—reportedly around 30,000 since October—that management has linked to efficiency gains from automation, raising questions about the balance between AI ambition and workforce impact.
BioNTech's stock faces pressure following a Leerink Partners downgrade, which tempered near-term optimism around its oncology pipeline after a recent rally. The move highlights investor reassessment of catalysts amid mixed long-term performance.
The 106-year-old outdoor apparel brand, founded in Seattle in 1920, could see nearly 200 of its North American stores shuttered as its licensed operator moves toward Chapter 11 restructuring, though core brand operations are expected to continue.
Fifth Third Bancorp has finalized its $12.3 billion acquisition of Comerica Bank, with customer system conversions and branch rebranding to begin in September. The deal creates the ninth-largest U.S. bank and significantly expands Michigan's branch network, though some closures and layoffs are expected.
A landmark all-stock merger between Devon Energy and Coterra Energy will create a $58 billion powerhouse, positioning it as a top-tier producer in the prolific Permian Basin amid a wave of industry consolidation.
The surge in popularity of weight-loss drugs like Ozempic and Wegovy is sending shockwaves far beyond the pharmacy, fundamentally altering consumer spending, challenging major corporations, and forcing a broad economic recalibration.
U.S. stocks advanced cautiously Monday as investors braced for a wave of corporate earnings reports, while crude oil prices tumbled sharply. The focus remains on key tech results and evolving geopolitical developments affecting global trade and energy markets.
IDEAYA Biosciences shares have retreated from recent highs, sparking debate among investors. While a discounted cash flow model suggests deep undervaluation, price-to-sales metrics paint a contrasting picture of a premium stock. We examine the numbers behind the volatility and what it signals for the precision oncology company's future.
Fresh financial data from QuidelOrtho reveals ongoing challenges, including constant currency revenue declines and pressured cash flow, forcing investors to weigh the stock's risk-reward profile as its momentum appears to fade.
IAMGOLD (TSX:IMG) has reignited drilling at its Anik joint venture in Québec and issued updated production guidance, signaling accelerating operational momentum. The moves come as the gold miner's shares, despite recent volatility, have delivered staggering multi-year returns, highlighting a potential valuation gap.
While Wall Street chases the latest weight-loss drug headlines, Novo Nordisk's recent launch of an oral GLP-1 therapy and its entrenched insulin business present a compelling value proposition for long-term investors.
The Detroit automaker has held preliminary talks with Xiaomi and other Chinese manufacturers about potential joint ventures to build electric vehicles in the United States, a move already drawing sharp criticism from Washington lawmakers.
French pharmaceutical giant Sanofi has discontinued development of its experimental mRNA flu vaccine, citing a strategic reprioritization. The decision comes as influenza activity remains high across much of the United States, with significant hospitalizations and deaths reported this season.
In a significant diplomatic and economic shift, the Trump administration has agreed to slash tariffs on Indian goods after securing a commitment from New Delhi to phase out purchases of Russian crude oil.
Bitcoin clawed back some of its steep weekend losses in Monday trading, though the broader digital asset sector and related equities remained under significant selling pressure as investors digested a wave of forced liquidations and awaited key U.S. economic data.
An examination of price data reveals that tariffs imposed during the previous administration continue to contribute to higher costs for everyday goods, from groceries to home utilities, adding financial pressure on U.S. households.
